Ibere Pharmaceuticals

Status: Pre-Deal
U=S+W/2 W=S@11.5
IPO Proceeds, $M $138.0
IPO Date Feb 26, 2021
CEO Osagie Imasogie
Left Lead Raymond James
IPO Cash in Trust 100%
SPAC Tenor 24 months
IPO Sector Healthcare
IPO Geography Global
Target Company TBD
Deal Announced TBD
Deal Size, $M TBD
Deal Geography TBD
Deal Sector TBD
SEC Filings www.sec.gov
IBER IBER.U IBER/W


Sign up for Free Trial

No credit card required

Sign in for more data on Ibere Pharmaceuticals:

  • 7 directors & officers
  • 5 filings and events
  • 1 underwriters
  • 58 shareholders (from 13F filings)